| Lipid Composition for LPS-501 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 9.03 | 11.14 | 90 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.97 | 1.24 | 10 |
| Total | 10.00 mg/vial | 12.38 umol | 100 |
| Lipid Composition for LPS-502 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 8.05 | 9.94 | 80 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 1.95 | 2.48 | 20 |
| Total | 10.00 mg/vial | 12.42 umol | 100 |
| Lipid Composition for LPS-503 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 7.06 | 8.72 | 70 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 2.94 | 3.74 | 30 |
| Total | 10.00 mg/vial | 12.46 | 100 |
| Lipid Composition for LPS-504 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 6.07 | 7.49 | 60 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 3.93 | 5.00 | 40 |
| Total | 10.00 mg/vial | 12.49 umol | 100 |
| Lipid Composition for LPS-505 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 5.07 | 6.27 | 50 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 4.93 | 6.27 | 50 |
| Total | 10.00 mg/vial | 12.54 umol | 100 |
| Lipid Composition for LPS-506 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 4.07 | 5.03 | 40 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 5.93 | 7.54 | 60 |
| Total | 10.00 mg/vial | 12.57 umol | 100 |
| Lipid Composition for LPS-507 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 3.06 | 3.78 | 30 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 6.94 | 8.83 | 70 |
| Total | 10.00 mg/vial | 12.61 umol | 100 |
| Lipid Composition for LPS-508 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 2.05 | 2.53 | 20 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 7.95 | 10.11 | 80 |
| Total | 10.00 mg/vial | 12.64 umol | 100 |
| Lipid Composition for LPS-509 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 1.03 | 1.27 | 10 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 8.97 | 11.41 | 90 |
| Total | 10.00 mg/vial | 12.68 umol | 100 |
| Lipid Composition for LPS-510 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 0.51 | 0.64 | 5 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 9.49 | 12.07 | 95 |
| Total | 10.00 mg/vial | 12.71 umol | 100 |
| Lipid Composition for LPS-511 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 0.21 | 0.25 | 2 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 9.79 | 12.46 | 98 |
| Total | 10.00 mg/vial | 12.71 umol | 100 |
| Lipid Composition for LPS-512 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 0.10 | 0.13 | 1 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 9.90 | 12.59 | 99 |
| Total | 10.00 mg/vial | 12.72 umol | 100 |
| Lipid Composition for LPS-513 | Amount (mg/vial) | Amount (umol) | Molar Ratio Percentage |
|---|---|---|---|
| 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) | 0.05 | 0.06 | 0.5 |
| 1,2-dioleoyl-sn-glycero-3-phosphocholine | 9.95 | 12.66 | 99.5 |
| Total | 10.00 mg/vial | 12.72 umol | 100 |
